Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women

Metabolism: Clinical and Experimental

Volumn 60, Issue 9, 2011, Pages 1211-1221

  Sienkiewicz, Elizabeth ^a   Magkos, Faidon ^a   Aronis, Konstantinos N ^a   Brinkoetter, Mary ^a   Chamberland, John P ^a,b   Chou, Sharon ^a   Arampatzi, Kalliopi M ^a   Gao, Chuanyun ^a   Koniaris, Anastasia ^a   Mantzoros, Christos S ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; ESTRADIOL; HYDROCORTISONE; METRELEPTIN; PLACEBO; RECOMBINANT LEPTIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AMENORRHEA; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TEST; FEMALE; HIP; HUMAN; HYPOLEPTINEMIA; LEAN BODY WEIGHT; LONG TERM CARE; LUMBAR SPINE; METABOLIC PARAMETERS; OPEN STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RADIUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE REMODELING; EXERCISE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LUMBAR VERTEBRAE;

EID: 80051800457     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.05.016     Document Type: Article

References (53)

1. K. Christo, J. Cord, and N. Mendes Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study Clin Endocrinol (Oxf) 69 2008 628 633
2. G.A. Laughlin, and S.S. Yen Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea J Clin Endocrinol Metab 82 1997 318 321 (Pubitemid 27021319)
3. M.J. Rauh, J.F. Nichols, and M.T. Barrack Relationships among injury and disordered eating, menstrual dysfunction, and low bone mineral density in high school athletes: a prospective study J Athl Train 45 2010 243 252
4. F.S. Thong, C. McLean, and T.E. Graham Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors J Appl Physiol 88 2000 2037 2044 (Pubitemid 30453908)
5. C.S. Mantzoros Role of leptin in reproduction Ann N Y Acad Sci 900 2000 174 183 (Pubitemid 30251467)
6. C.M. Gordon Clinical practice. Functional hypothalamic amenorrhea N Engl J Med 363 2010 365 371
7. M.T. Barrack, M.J. Rauh, and J.F. Nichols Cross-sectional evidence of suppressed bone mineral accrual among female adolescent runners J Bone Miner Res 25 2010 1850 1857
8. C.E. Cann, M.C. Martin, and H.K. Genant Decreased spinal mineral content in amenorrheic women JAMA 251 1984 626 629 (Pubitemid 14221023)
9. B.L. Drinkwater, K. Nilson, and C.H. Chesnut III Bone mineral content of amenorrheic and eumenorrheic athletes N Engl J Med 311 1984 277 281 (Pubitemid 14091204)
10. K. Christo, R. Prabhakaran, and B. Lamparello Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects Pediatrics 121 2008 1127 1136
11. S. Grinspoon, L. Thomas, and K. Miller Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa J Clin Endocrinol Metab 87 2002 2883 2891 (Pubitemid 34655358)
12. J.D. Vescovi, S.A. Jamal, and M.J. De Souza Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature Osteoporos Int 19 2008 465 478
13. S.L. Liu, and C.M. Lebrun Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review Br J Sports Med 40 2006 11 24 (Pubitemid 43028585)
14. C.B. Confavreux, R.L. Levine, and G. Karsenty A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms Mol Cell Endocrinol 310 2009 21 29
15. G. Karsenty Convergence between bone and energy homeostases: leptin regulation of bone mass Cell Metab 4 2006 341 348 (Pubitemid 44645074)
16. N.K. Lee, and G. Karsenty Reciprocal regulation of bone and energy metabolism Trends Endocrinol Metab 19 2008 161 166 (Pubitemid 351847838)
17. M.P. Warren Endocrine manifestations of eating disorders J Clin Endocrinol Metab 96 2011 333 343
18. Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci U S A 2011 In press: doi: 10.1073/pnas.1015674108.
19. C.K. Welt, J.L. Chan, and J. Bullen Recombinant human leptin in women with hypothalamic amenorrhea N Engl J Med 351 2004 987 997 (Pubitemid 39166262)
20. J.L. Chan, and C.S. Mantzoros Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa Lancet 366 2005 74 85 (Pubitemid 40956533)
21. Iwaniec UT, Boghossian S, Trevisiol CH, et al. Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats. J Bone Miner Res 2011; doi: 10.1002/jbmr.1365.
22. P. Pogoda, M. Egermann, and J.C. Schnell Leptin inhibits bone formation not only in rodents, but also in sheep J Bone Miner Res 21 2006 1591 1599 (Pubitemid 44484604)
23. F. Elefteriou, S. Takeda, and K. Ebihara Serum leptin level is a regulator of bone mass Proc Natl Acad Sci U S A 101 2004 3258 3263 (Pubitemid 38327768)
24. S. Takeda, F. Elefteriou, and R. Levasseur Leptin regulates bone formation via the sympathetic nervous system Cell 111 2002 305 317 (Pubitemid 35345151)
25. P. Ducy, M. Amling, and S. Takeda Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 2000 197 207 (Pubitemid 30064908)
26. J.L. Chan, K. Heist, and A.M. DePaoli The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men J Clin Invest 111 2003 1409 1421 (Pubitemid 36554712)
27. J.L. Chan, J.E. Mietus, and P.M. Raciti Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans Clin Endocrinol (Oxf) 66 2007 49 57 (Pubitemid 44952494)
28. T. Thomas, F. Gori, and S. Khosla Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes Endocrinology 140 1999 1630 1638 (Pubitemid 29149231)
29. G. Maor, M. Rochwerger, and Y. Segev Leptin acts as a growth factor on the chondrocytes of skeletal growth centers J Bone Miner Res 17 2002 1034 1043 (Pubitemid 34535141)
30. J. Cornish, K.E. Callon, and U. Bava Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo J Endocrinol 175 2002 405 415 (Pubitemid 35414387)
31. J.O. Gordeladze, C.A. Drevon, and U. Syversen Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling J Cell Biochem 85 2002 825 836 (Pubitemid 34462792)
32. C.M. Steppan, D.T. Crawford, and K.L. Chidsey-Frink Leptin is a potent stimulator of bone growth in ob/ob mice Regul Pept 92 2000 73 78
33. B. Burguera, L.C. Hofbauer, and T. Thomas Leptin reduces ovariectomy-induced bone loss in rats Endocrinology 142 2001 3546 3553 (Pubitemid 32681763)
34. W.R. Holloway, F.M. Collier, and C.J. Aitken Leptin inhibits osteoclast generation J Bone Miner Res 17 2002 200 209 (Pubitemid 34087652)
35. M.W. Hamrick, M.A. Della Fera, and Y.H. Choi Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow Cell Tissue Res 327 2007 133 141 (Pubitemid 44833056)
36. M.W. Hamrick, M.A. Della-Fera, and Y.H. Choi Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice J Bone Miner Res 20 2005 994 1001eq 37 (Pubitemid 40712824)
37. O. Israel, R. Lubushitzky, and A. Frenkel Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis J Nucl Med 35 1994 1155 1158
38. A. Miyauchi, T. Matsumoto, and T. Sugimoto Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases Bone 47 2010 493 502
39. J.R. Zanchetta, C.E. Bogado, and C. Cisari Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study Curr Med Res Opin 26 2010 2627 2633
40. D.C. Cumming Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy Arch Intern Med 156 1996 2193 2195 (Pubitemid 26361911)
41. M.P. Warren, K.K. Miller, and W.H. Olson Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study Contraception 72 2005 206 211 (Pubitemid 41133363)
42. M.J. Kempers, T. Vulsma, and B.M. Wiedijk The effect of life-long thyroxine treatment and physical activity on bone mineral density in young adult women with congenital hypothyroidism J Pediatr Endocrinol Metab 19 2006 1405 1412 (Pubitemid 46043772)
43. C.D. Rubin, B. Reed, and K. Sakhaee Treating a patient with the Werner syndrome and osteoporosis using recombinant human insulin-like growth factor Ann Intern Med 121 1994 665 668
44. Y.S. Chyun, B.E. Kream, and L.G. Raisz Cortisol decreases bone formation by inhibiting periosteal cell proliferation Endocrinology 114 1984 477 480 (Pubitemid 14183247)
45. M.S. Cooper, H.E. Syddall, and C.H. Fall Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study Clin Endocrinol (Oxf) 62 2005 692 697 (Pubitemid 40825939)
46. L. Futo, J. Toke, and A. Patocs Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome Osteoporos Int 19 2008 941 949
47. A. Bosy-Westphal, W. Later, and B. Schautz Impact of intra- and extra-osseous soft tissue composition on changes in bone mineral density with weight loss and regain Obesity (Silver Spring) 2011
48. J.F. Griffith, and H.K. Genant Bone mass and architecture determination: state of the art Best Pract Res Clin Endocrinol Metab 22 2008 737 764
49. G. Theintz, B. Buchs, and R. Rizzoli Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects J Clin Endocrinol Metab 75 1992 1060 1065
50. L.K. Bachrach Acquisition of optimal bone mass in childhood and adolescence Trends Endocrinol Metab 12 2001 22 28 (Pubitemid 33713182)
51. K. Mulligan, H. Khatami, and J.M. Schwarz The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia J Clin Endocrinol Metab 94 2009 1137 1144
52. S.B. Heymsfield, A.S. Greenberg, and K. Fujioka Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial JAMA 282 1999 1568 1575 (Pubitemid 29504050)
53. B.L. Drinkwater, K. Nilson, and S. Ott Bone mineral density after resumption of menses in amenorrheic athletes JAMA 256 1986 380 382 (Pubitemid 16093270)